Deutsche Bank Aktiengesellschaft Lowers Koninklijke DSM (OTCMKTS:RDSMY) Price Target to €170.00

Koninklijke DSM (OTCMKTS:RDSMYGet Rating) had its price objective lowered by investment analysts at Deutsche Bank Aktiengesellschaft from €180.00 ($183.67) to €170.00 ($173.47) in a research note issued on Friday, The Fly reports.

RDSMY has been the topic of several other research reports. Credit Suisse Group lowered their target price on Koninklijke DSM from €182.00 ($185.71) to €162.00 ($165.31) and set an “outperform” rating on the stock in a research note on Wednesday, July 13th. Jefferies Financial Group raised Koninklijke DSM from a “hold” rating to a “buy” rating in a research note on Wednesday, September 14th. Finally, Sanford C. Bernstein raised Koninklijke DSM from a “market perform” rating to an “outperform” rating in a research note on Tuesday, June 14th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to, the stock currently has an average rating of “Moderate Buy” and an average target price of $172.00.

Koninklijke DSM Price Performance

Koninklijke DSM stock traded down $0.60 during midday trading on Friday, hitting $28.24. The company’s stock had a trading volume of 138,674 shares, compared to its average volume of 91,490. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.52 and a quick ratio of 1.58. The stock’s 50-day moving average price is $34.65 and its 200-day moving average price is $38.24. Koninklijke DSM has a 12 month low of $28.02 and a 12 month high of $56.92.

Koninklijke DSM Company Profile

(Get Rating)

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.

Recommended Stories

The Fly logo

Analyst Recommendations for Koninklijke DSM (OTCMKTS:RDSMY)

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with's FREE daily email newsletter.